US Stock Movers
Live U.S. stock market movers ranked by gains, losses & volume with AI-powered reasons for every move.
| Name | Price | Today | Market Cap | Event Catalyst |
|---|---|---|---|---|
| $0.222 | -55.58% | 3.45M | CIMG's partnership with iZUMi raised concerns, negatively impacting investor sentiment. | |
| $0.677 | -50.87% | 17.32M | Medicus Pharma reported positive clinical trial results, but market sentiment led to a significant stock price drop. | |
| $1.080 | -36.84% | 395.95M | SES AI's stock fell due to an earnings miss and significant revenue shortfall. | |
| $5.640 | -33.88% | 282.20M | Shares fell 13% despite positive Phase 2 results due to investor caution regarding market potential. | |
| $0.705 | -32.86% | 2.29M | PMGC Holdings announced a 1-for-6 reverse stock split, indicating financial distress for ELAB. | |
| $0.552 | -29.11% | 169.42M | Q4 earnings missed expectations, with GAAP EPS at -$0.12, leading to a significant stock decline. | |
| $6.340 | -27.87% | 622.29M | Grocery Outlet's stock dropped 24.91% after missing Q4 EPS estimates by $0.02 and facing a downgrade. | |
| $5.405 | -27.11% | 83.98M | FTCI's stock dropped significantly despite beating EPS expectations, amidst broader market declines and sector losses. | |
| $5.110 | -27.00% | 5.56M | VCI Global's stock surged 75% after launching Malaysia's first Nvidia-powered AI Computing Center. | |
| $0.394 | -26.89% | 3.45M | ASNS's stock fell 29.50% due to profit-taking after a significant previous gain of 186.56%. | |
| $3.960 | -26.80% | 213.86M | SGHT's stock dropped sharply due to a $4.16 million net loss despite revenue growth. | |
| $21.900 | -26.29% | 1.01B | DSGR's stock price fell due to weak earnings and poor sector performance. | |
| $0.500 | -26.27% | 1.53M | -- | |
| $0.152 | -25.38% | 6.92M | Decent Holding reported a quarterly loss of $0.02 EPS, impacting investor sentiment negatively. | |
| $5.950 | -25.35% | 421.71M | CD's stock dropped significantly after a sharp gain, amid negative sector and market trends. | |
| $4.600 | -23.59% | 6.02M | Positive trial results led to a 40% surge, followed by profit-taking and subsequent decline. | |
| $0.219 | -22.28% | 4.21M | -- | |
| $0.0748 | -21.85% | 2.30M | Classover's partnership with YuGang AI boosted investor optimism, impacting KIDZ's stock performance. | |
| $4.390 | -21.61% | 638.44M | Lightwave Logic reported a Q4 GAAP EPS of -$0.04, raising concerns over profitability. | |
| $2.450 | -21.47% | 3.65M | -- | |
| $0.275 | -20.27% | 250.62M | KALA's stock surged 14% premarket after announcing an AI licensing agreement before dropping significantly. | |
| $4.240 | -19.85% | 359.22M | Ranpak reported Q4 EPS of -$0.11, missing expectations and raising investor concerns about profitability. | |
| $0.0501 | -19.48% | 10.93M | GSIW announced a 200-for-1 share consolidation, causing significant investor caution and stock price decline. | |
| $1.170 | -18.75% | 19.13M | Delixy Holdings surged 158.03% amid supply concerns before a significant intraday drop of 17.47%. | |
| $1.620 | -18.59% | 640.17M | Bernstein downgraded Sabre to Market Perform, lowering the target price from $3 to $1.5. | |
| $5.505 | -18.57% | 380.48M | FDA partially halted PepGen's clinical trial, causing a significant decline in investor confidence. | |
| $4.210 | -18.41% | 78.29M | -- | |
| $3.505 | -17.92% | 438.94M | Altimmune's Q4 earnings report missed expectations, leading to a significant decline in stock price. | |
| $1.465 | -17.70% | 980.20M | OLPX's stock fell despite beating Q4 earnings, indicating mixed investor sentiment. | |
| $1.310 | -17.61% | 1.74M | Jiuzi Holdings expanded financing to $300 million, raising concerns about potential dilution. | |
| $30.710 | -16.84% | 310.00M | -- | |
| $2.050 | -16.67% | 116.80M | -- | |
| $0.155 | -16.65% | 31.26M | Tevogen's 1-for-50 reverse stock split aims to regain Nasdaq compliance, affecting over 70% of shareholders. | |
| $0.52 | -16.52% | 13.11M | -- | |
| $25.060 | -16.24% | 382.35M | Q4 EPS of -$0.32 missed expectations by $0.35, indicating significant profitability challenges. | |
| $21.690 | -16.19% | 97.18M | -- | |
| $18.320 | -15.65% | 45.92M | -- | |
| $0.570 | -15.56% | 889.58K | -- | |
| $9.115 | -15.52% | 210.74M | MRAM's stock dropped due to missed Q4 earnings expectations, raising investor concerns. | |
| $1.530 | -15.47% | 39.36M | -- | |
| $3.610 | -15.46% | 30.14M | -- | |
| $11.710 | -14.96% | 230.89M | -- | |
| $0.335 | -14.75% | 16.82M | -- | |
| $5.830 | -14.39% | 809.54M | Recent earnings call revealed soft demand for new construction, impacting stock sentiment negatively. | |
| $15.720 | -14.38% | 283.74M | -- | |
| $0.341 | -14.08% | 6.45M | -- | |
| $0.615 | -13.97% | 34.89M | -- | |
| $19.330 | -13.90% | 3.28B | AEO's stock dropped despite beating Q4 earnings estimates due to year-over-year earnings decline. | |
| $7.830 | -13.86% | 225.17M | -- | |
| $41.060 | -13.86% | 3.74B | Delayed Preliminary Economic Assessment report contributed to HYMC's stock price decline. |
